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Summary 
CD8 + T  cell clones  specific for a defined epitope present in the circumsporozoite protein of 
Plasmodium yoelii display striking differences in their in vivo antiplasmodial activity. The adoptive 
transfer of certain dones (YA23 and YA26) into naive mice inhibits by 90% or more the development 
of liver stages of malaria parasites and protects against malaria infection. The adoptive transfer 
of two other T cell clones (YB8 and YA15) results, respectively, in partial or no inhibitory activity 
on parasite development. We found that "protective" and "nonprotective" cytotoxic T lymphocyte 
(CTL) clones do not differ in their fine epitope specificity and display similar levels of lysis and 
DNA degradation of target cells in vitro. Their pattern of production of lymphokines and granule- 
associated proteins also failed to correlate with their in vivo antiplasmodial activity. Histological 
studies combined with autoradiography showed that, upon adoptive transfer, only T cells from 
the protective CTL clones are capable of"associating" with a significant percentage of parasitized 
hepatocytes.  Fluorescence-activated  cell sorter analysis of surface molecules revealed pronounced 
differences in the levels of CD44 and VLA-4 expression by the different clones, correlating closely 
with their in vivo protective activity. The correlation between in vivo antiparasite  activity and 
the expression of CD44 was further corroborated by the results of sorting, from the partially 
protective YB8 clone, two sub-populations expressing high and low levels of CD44. These were 
protective and nonprotective, respectively. The clones also differed in their adhesive properties. 
Cross-linking of CD44, using specific antibodies, induced LFA-l-mediated homotypic aggregation 
of protective clones,  while nonprotective cells failed to aggregate. 
A  number of recent experimental findings have provided 
evidence that CD8 § T cells, induced by immunization 
with radiation-attenuated sporozoites, play an important role 
in immunity against the liver stages of malaria parasites. Re- 
cently, we obtained CD8 + T  cell clones  directed against 
defined epitopes present in the circumsporozoite (CS) 1 pro- 
teins of two rodent malaria species, Plasmodium berghei and 
P. yoelii (1, 2). Some of these clones inhibit the development 
of the intrahepatocytic stages of the corresponding malaria 
parasites when adoptively transferred to naive mice and pro- 
tect these mice against malaria  infection. 
A  surprising finding of these studies was that different 
1 Abbreviations used in this paper: CS, circumsporozoite; LT, lymphotoxin. 
CD8 § T  cell clones displayed striking differences with re- 
gard to their in vivo antiplasmodial activity.  Using a quan- 
titative method, based  on the measurement of plasmodial 
ribosomal RNA in the liver of P. yoelii-infected  mice, we 
compared the in vivo antiparasite  activity of various CD8 + 
T cell clones. We found that the development ofP. yoelii liver 
stages could be inhibited, by 90% or more, when naive mice 
were injected with the T cell clones YA26 or YA23, and by 
50-60% when the mice received the YB8 T  cell clone.  In 
contrast, the adoptive transfer of T cell clone YA15 had no 
detectable antiparasite  effect, although clones YA23, YA26, 
and YA15 were derived in the course of the same cloning 
procedure from the spleen cells of a single mouse immunized 
with sporozoites (2). 
To elucidate the basis of the functional heterogeneity dis- 
played by these T  cell clones, we undertook detailed com- 
parative  studies aimed at characterizing their fine epitope 
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tion, and localization after adoptive transfer. The results of 
the present study indicate that protective and nonprotective 
clones differ in their capacity to associate in vivo with para- 
sitized liver cells and that their protective capacity correlates 
closely with the expression of certain defined adhesion mol- 
ecules. 
Materials and Methods 
Parasites and Animals.  P. yoelii (17X NL strain) was maintained 
by repeated cyclic passage  of the parasites  in Anopheles stephensi 
mosquitoes and BALB/c mice. Sporozoites were collected by dis- 
secting the mosquito salivary glands in medium 199, -~2 wk after 
their infective blood meal. 
4-8-wk-old female BALB/c mice used for the immunological 
studies were purchased from The Jackson Laboratories (Bar Harbor, 
ME) and from Charles River Laboratories (Wilmington, MA). Mice 
were challenged intravenously with the indicated dose of viable 
sporozoites. 
Cell Culture.  As culture medium, we used DME-high glucose 
(Grand Island Biological Co., Long Island, NY), supplemented with 
0.2 g/liter of t-arginine (Calbiochem-Behring Co., La Jolla, CA), 
0.036 g/liter of t-Asparagine (Gibco Laboratories,  Grand Island, 
NY), 10 mM Hepes, 2 mM t-Glutamine, and 10% FCS (HyClone 
Laboratories, Logan, UT). For growth and maintenance of the CTL 
clones, we also added to the medium 5  x  10 -S M 2-ME and 2% 
ofT ceU growth factor medium, derived from PMA- (Sigma Chem- 
ical Co., St. Louis,  MO) activated EL-4 cells. The cultures were 
maintained at 37~  in an atmosphere containing 5% CO2. 
Stimulation and Adoptive Transfer of CTL  Clones.  CTL clones 
were established and maintained as described (2). Briefly, CTL clones 
(1.25  x  105) were restimulated weekly with irradiated  feeder ceUs 
(2.5  x  106 cells/ml), and irradiated P815 cells (1.25  x  105 cells/ 
ml) pulsed with 1/~M of peptide Py 277-288.  4 d later, and after 
the addition of an equal volume of medium,  the cultures were 
divided and grown under the same conditions for an additional 
2-3  d.  The desired  number of T  ceUs was  centrifuged and re- 
suspended  in DME  containing 2  x  105 U/ml  of human  rib2 
(kindly provided by Hoffmann-La Roche, Inc., Nutley, NJ), im- 
mediately before transfer. A total volume of 0.5 ml of the ceU sus- 
pension or IL-2 alone was injected intravenously into each mouse. 
The timing of cell transfer in relation to sporozoite challenge varied 
from 6 h before to 24 h after parasite  inoculation as specified in 
the figure legends. 
Quantification of P. yoelii rRNA  in  the Liver of Infected Mice. 
Quantification of P.. yoelii rR.NA was performed as described (3). 
Briefly, total RNA was isolated from the livers of mice killed 42 h 
after they had been injected intravenously with 5  x  105 sporo- 
zoites of P. yoelii. RNA was prepared by the method of Chom- 
czynski and Sacchi (4). 10% of the whole liver RNA was precipi- 
tated with isopropanol. The RNA peUet was dissolved in 10 mM 
Tris-HC1, pH 8.0, 1 mM EDTA, denatured at 65~  in 20x  SSC 
(lx  SSC is 150 mM NaC1, 15 mM Na Citrate) plus 37% formal- 
dehyde (1:1). This preparation was diluted 45 times, and 0.2-ml 
samples were blotted onto nylon membranes. The RNA was fixed 
to the filters by UV crosslinking. Hybridization was performed 
overnight in 5 x  SSPE (lx  SSPE contains 180 mM NaC1, 10 mM 
Na phosphate,  I mM EDTA, pH 7.7), 1% SDS, and 500/~g heparin 
at 42~  containing three oligonucleotide probes labeled with 32p 
(10  + cpm/ml; sp act >2  x  10  s cpm/#g). Filters were washed twice 
in 6x  SSC  +  0.1% SDS and once with lx  SSC +  SDS, at room 
temperature for 15 min. The membranes were dried, the spots on 
the filters were cut out, and the radioactivity was measured in a 
liquid scintillation counter. For comparison purposes, a standard 
curve was prepared using serial dilutions of purified RNA from 
P. yoelii-infected erythrocytes, blotted under the same conditions. 
Chromium Release Assay.  For this in vitro cytolytic assay, we 
used a P815 (H-2  a) cell line,  standardly used as a target cell,  la- 
beled with 250 #Ci of SlCr (ICN Biomedicals, Irvine, CA). After 
washing,  2  x  103 P815 cells per well were cultured with 104 CTL, 
in the presence of the desired concentration of peptide. After 4 h 
at 37~  the supernatants were collected with the aid of a semi- 
automatic harvester (Skatron, Inc., Sterling, VA). The percentage 
of specific lysis was calculated  as follows:  100  x  (experimental - 
spontaneous release cpm/total  -  spontaneous release). 
DNA Degradation Assay.  The target cells were P815 cells, la- 
beled overnight with 5/~Ci/ml of [3H]thymidine (6.7 Ci/mM; 
New England Nuclear, Boston, MA). The assay was performed 
in 1.5-ml microfuge tubes, where target ceils (104) were cultured 
at 37~  with different ratios of CTL in the presence or absence 
of peptide Py 277-288  (1/~M) in a final volume of 0.2 ml. After 
2 h, each sample received 1 ml of lysis buffer (20 mM Tris, 1 mM 
EDTA, 0.2% Triton X-100 [vol/vol]; pH 8.0). These samples were 
centrifuged for 10 rain at 12,000 g, and 0.6 ml of sample superna- 
tants was collected and counted in a scintillation counter. The per- 
centage of specific  DNA degradation was calculated as follows: 100x 
(experimental  -  spontaneous release cpm/total  -  spontaneous 
release). 
IFN-% TNF/Lymphotoxin (LT), and BLT-Esterase Determination. 
P815 cells were pulsed with 1 #M of peptide Py 277-288 for 30 
min before the assay. 106/ml of these target cells were cultured 
with the same amount of  CTL in 96-well V-bottomed plates (Costar, 
Cambridge, MA). The final volume was 0.2 ml, and the cultures 
were kept at 37~  After 6 h of incubation, the plates were cen- 
trifuged, and the culture supernatants were collected and used to 
measure IFN-%  TNF/LT, and BLT-esterase. 
The amount of IFN-'y was determined by RIA,  as described 
(1). Murine rIFN-y (Genentech, San Francisco,  CA) was used as 
a standard. 
The TNF/LT bioassay was performed as described (5). Briefly, 
3  x  105 b929 ceUs were seeded in 96-well flat-bottomed culture 
plates (Costar). Culture supernatants from CTL, generated as de- 
scribed above, were added in a 0.1-ml volume at a final concentra- 
tion of 50% (vol/vol). Recombinant TNF-cx (Genentech) was used 
as standard.  After 24 h, L cell survival was evaluated by the incor- 
poration, in the course of four hours, of 3-[4,5-dimethylthiazol-2- 
yl]-2,5-diphenyltetrazolium  bromide (MTT) (Sigma Chemical Co.). 
The  cell  suspension  was  then  acidified  with  100  #1  of acid 
isopropanol. After 5 rain, 100/~1 of water was added to each well 
and kept at room temperature for 1 h before reading at 470 nM. 
BLT-esterase activity was detected by adding 20 #1 of culture su- 
pematants in 0.18 ml of Tris-HC1 buffer (20 rnM Tris, 1 mM EDTA, 
pH 7.5) containing 200/~M of 5,5'-Dithio-bis (2-nitrobenzoic acid; 
Sigma Chemical Co.) and 220 #M ofN-benzyloyx  carbonyl L-lysine 
thiobenzilester (BUI~ Sigma Chemical Co.). The samples were kept 
at room temperature for 30 rain before reading at 405  riM. 
Synthetic Peptides.  A  series of nested peptides containing the 
CTL epitope of the CS protein of P. yoelii was synthesized as de- 
scribed  (6). 
Labeling of CTL.  CTLs were harvested 6-7 d after restimula- 
tion with peptide. After being washed in methionine-free RPMI 
(Gibco Laboratories), the CTL (5  x  106 cells/ml) were incubated 
in  the same  medium containing  10%  of dialyzed FCS and  100 
/~Ci/ml of 3sS-Methionine  (New England Nuclear). After 2 h at 
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adoptively transferred to BALB/c mice (2.0  x  107 per mouse), 
which had been infected with  106 sporozoites, 24 h earlier. 
Tissue Fixation, Embedding, Sections  and Autoradiography.  Livers 
from mice injected only with parasites, or with parasites and CTL 
clones, were fixed overnight in PBS containing 10% (vol/vol) for- 
malin, dehydrated through a graded series (70%, 95%, and 100%) 
of ethanol, 100% chloroform, and embedded in paraffin.  Trans- 
verse sections of paraffin blocks were cut at 4-#m thickness and 
mounted on glass slides. Depara~nation was performed by dip- 
ping slides into xylene and subsequently rehydrating them by pas- 
sage through a graded series of ethanol (100%, 90%, and 70%) 
and finally tap water. Slides were dipped in Kodak NTB-2 emul- 
sion (Kodak, Rochester, NY) prediluted 1:3 with distilled  water, 
and equilibrated at 42~  The dipped slides containing the tissue 
samples were dried, and the exposure in a desiccator was continued 
for 24-48 h at 4~  Slides were developed in Kodak D-19, at 21~ 
for 6 min, and counterstained with hematoxylin and eosin according 
to standard protocols. 
Flow Cytometry and Cell Sorting.  106 T cells were incubated for 
45 min, on ice, with purified antibodies, undiluted hybridoma su- 
pernatants, or hybridoma supernatants precipitated with ammo- 
nium sulfate. After being washed twice, cell samples were incubated 
with fluorescein-labeled  goat anti-rat IgG or goat anti-hamster 
IgG (KPL Inc., Gaithersburg, MD), for an additional 45 rain on 
ice, washed, and fixed in PBS containing 2% (wt/vol) of parafor- 
maldehyde. Fluorescence was analyzed in a FACScan  |  cytometer 
(Becton Dickinson & Co., Mountain View, CA), gating for size 
by forward and side ward light scatter,  both amplified on linear 
scales. The fluorescence signals were amplified on a logarithmic scale. 
The following rat IgG mAbs were used for staining: anti-CD8 
(2.4.3), anti-LFA-1 (FD441.8), anti+selectin (MEL-14), anti-ICAM- 
1 (YN1/1.7.4), anti-CD44 (KM 703, KM 201), anti-CD45Ra (TIB 
164), all purchased from American Type Culture Collection (ATCC; 
Rockville, MD). Other rat mAbs used were: anti-VLA-4/LPAM-1 
(R1-2; Pharmingen, San Diego, CA); anti-CD45 (M1/9.3.4 H2- 
2) and CD45Rb (4B4) (a kind gift from Dr. E. Pure, The Rock- 
efeller University, New York); anti-V3 8.1 and 8.2 (KJ16), anti-V~ 
8.2 (F23.2), and anti-CD44 (IM7.8.1) (kindly provided by Dr. H. 
R. McDonald, Ludwig Institute for Cancer Research, Lausanne 
Branch, Switzerland); anti-CD2 (RM2-2) kindly provided by Dr. 
A. Sen, Dana-Farber Cancer Institute, Boston, MA). The hamster 
IgG mAb to the vitronectin receptor (H9-2B8) was kindly provided 
by Dr. E. Shevach (NIAID, Bethesda, MD). For cell sorting, we 
used an EPIC 752 (Coulter Electronics Inc., Hialeah,  FL). 
Aggregation Assay.  CTL cells were harvested 7 d after restimu- 
lation with irradiated feeder cells and irradiated P815 target cells 
coated with peptide. These cells were washed five times in culture 
medium to eliminate dead cells and cell debris. The cell suspension 
obtained showed 99% or more viability and was seeded in 96-well 
flat-bottomed plates (Dinatech, Chantilly, VA). Each weU contained 
1.5  x  10  s T  cells. To these cells we added two mAbs to CD44 
(KM 201 and KM 703), at a final concentration of 5 #g/ml each, 
or 100 ng/ml of PMA, in a final volume of 0.2 ml. Some of the 
wells received 25~  of a supernatant containing anti-LFA-1 mAb. 
The plate was then centrifuged for 2 min and incubated at 37~ 
for 2 h. Cultures were photographed as viewed in an inverted phase 
contrast microscope. 
Results 
Protective and Nonprotective CD8 + CTL  Clones, Fine Epi- 
tope Specificity, and In Vitro Activities.  As previously described, 
protective  and  nonprotective  CDB*  T  cell clones  display 
similar levels of in vitro cytolytic activity when incubated 
with target cells coated with  the 12mer synthetic peptide, 
representing amino acids 277-288 of the P. yoelii CS protein 
(2). To further characterize the fine epitope specificity of the 
protective YA26  and  nonprotective YA15  clones,  cytolytic 
assays  were performed with a series of nested peptides. All 
these peptides contained the minimal amino acid sequence, 
comprised between the tyrosine and isoleucine residues, es- 
sential for the binding  of peptides  to H-2K  a MHC  mole- 
cules (6-8). As seen in Table 1, the two T  cell clones do not 
differ significantly in their capacity to recognize these different 
synthetic peptides, since both clones require similar peptide 
concentrations to induce 50% of maximal lysis of target cells. 
Both clones were most efficient when target cells were coated 
Table  1.  Recognition  of NHz-terminally  Truncated Synthetic Peptides Containing the P. yoelii Cytotoxic Epitope, by a Protective 
(YA26) and a Nonprotective (YA15) CTL  Clone 
Peptide concentration necessary 
for 50%  maximal lysis 
Pep  tide  Sequence  YA26  YA 15 
M 
277-288  NEDSYVPSAEQI  5.5  x  10 -1~  2.5  x  10 -1~ 
278-288  EDSYVPSAEQI  3.3  x  10 -1~  3.5  x  10 -1~ 
279-288  DSYVPSAEQI  9.0  x  10  TM  1.0  X 10 -10 
280-288  SYVPSAEQI  5.0  x  10 -12  2.2  x  10 -12 
281-288  YVPSAEQI  2.5  x  10  TM  1.6  x  10 -11 
Chromium-labeled P815 cells were incubated with various peptides at different concentrations, together with YA26 or YA15 CTLs, at a 5:1 E/T 
ratio. The results are expressed as the molar concentration of peptide required to obtain 50% lysis of target cells. The maximal specific  lysis obtained 
was 66% and 76%, using YA26 and YA15 clone, respectively. 
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Figure 1.  Protective (YA26) and nonprotective (YA15) CTL clones in- 
duce similar levels of DNA degradation of peptide-coated P815 cells. The 
CTL of both clones were incubated with target cells (squares),  or target 
cells that had been coated with 1 #M of peptide Py 277-288 (circles). 
with the 9met peptide, i.e.,  the peptide that binds more 
ef~ciently to the H-2K  d molecule (6,  7). 
In addition to lysis, these clones also induce DNA degra- 
dation in target cells. As shown in Fig. 1, both T cell clones 
(YA15 and YA26) have almost identical capacity to degrade 
the DNA of peptide-coated P815 target cells. 
The respective levels of granule-associated proteins believed 
to be involved in the cytolytic event also do not correlate with 
the observed differences in the antiparasite  activity of these 
two clones. The quantification of perforin in cell extracts of 
both clones, using a hemolytic assay, as well as the levels of 
BLT-esterase, consistently revealed that nonprotective YA15 
cells have greater perforin activity (data not shown) and pro- 
duce much larger amounts of BLT-esterase than YA26 cells 
(Fig.  2 A). 
Because IFN-'y and TNF/LT can inhibit the development 
of liver stages of malaria parasites (9, 10), we measured the 
production of these cytokines by these two clones after pep- 
tide stimulation. As shown in Fig. 2, B and C, no significant 
differences were observed in the capacity of these two clones 
to produce IFN-3( and TNF/LT. 
Migration of Protective and Nonprotective Clones to the Liver 
and within Its Parenchyma.  Since the liver stages are the target 
of protective CTL, a failure to migrate to the liver could ex- 
plain the inability of YA15 cells to eliminate malaria  para- 
sites. To study this question, we analyzed the circulation pat- 
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Figure 3.  Comparison of the association of protective (YA26) and non- 
protective (YA15) CTL clones with parasitized hepatocytes. Mice were 
infected with sporozoites and 24 h later injected with radiolabeled CTL 
clones￿9 The mice were killed 4 or 8 h after the transfer of T cells. Liver 
sections were observed microscopically  to determine the number (per cm  2) 
of labeled T cells (A). (/3) Percentage of parasitized cells associated with 
YA26 or YA15 cells, obtained by counting at least 500 parasitized cells. 
The "association" between parasitized hepatocyte and labeled T  cells is 
illustrated in Fig. 4. Results are expressed as the mean value  +  SE ob- 
tained by counting 5-10 sections. 
terns of protective and nonprotective clones,  labeled with 
51Cr, in the different organs of the recipient mice. We found 
that 2, 6, and 24 h after the adoptive transfer,  cells of the 
protective and the nonprotective clone reached the liver, lungs, 
spleen, and kidneys in comparable numbers. The maximum 
number of T  cells that reached the liver represented 24% 
and 17.8% of the original intravenous inoculum of YA15 and 
YA26 cells, respectively. These patterns of organ localization 
did not differ whether the adoptive transfer was performed 
on either naive or sporozoite-infected mice (data not shown). 
To determine the precise localization of the CTL clones 
within the liver, we performed histological studies combined 
with autoradiography. 35S-Methionine-labeled T cell clones 
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Figure  2.  Secretion  of  BLT-esterase, IFN-%  and 
TNF/LT by a protective  (YA26) and a nonprotective 
(YA15) CTL done. CTL were incubated with P815 target 
cells (-), or target cells that had been coated with 1 #M 
of peptide Py 277-288 (+). Supernatants were collected 
after 6 h and assayed for the different secretory products. 
Results are expressed as the mean value  of triplicate  cultures. 
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with sporozoites.  Their livers were excised 4 and 8 h after 
the cell transfer,  and the tissue  sections  were processed  for 
histology and autoradiography. As shown in Fig. 3 A, there 
was no significant difference  in the number of the two different 
radiolabeled T cell clones present in liver sections, confirming 
the previous results. 
There was, however, a striking difference with regard to 
the relationship that parasitized  hepatocytes establish  with 
the labeled T  cells of these two clones.  At 4 and 8 h after 
adoptive transfer, labeled protective YA26 cells could be seen 
"associated" with 30-40% of the parasitized hepatocytes (Fig. 
3 B). In contrast, in liver sections of mice that received YA15 
cells, only 2-4% of parasitized cells were seen in close associ- 
ation with T cells (Fig. 3 B). Parasitized hepatocytes and la- 
beled T cells were considered "associated" when found in close 
proximity, as illustrated in Fig. 4. Results of additional ex- 
periments carried out with a second protective CTL clone 
(YA23) also showed a high degree of association between par- 
asitized  hepatocytes and these T  cells (data  not shown). 
Expression of CD44 and VLA-4 by CTL Clones Correlates 
with  Their In  Vivo Antiparasite Activity.  Our  histological 
findings raised the possibility that protective and nonprotec- 
tive clones might differ in the expression  of surface mole- 
cules involved in adhesion and/or migration of T  cells. To 
identify possible differences in the expression of such surface 
molecules, FACS  |  analysis of YA26 and YA15 clones was per- 
formed using mAbs of various specificities. 
Both CTL clones display a VB 8.1 TCR, which is expressed 
at similar levels. No differences were found in the expression 
of CD45 and CD45Rb by these two T cell clones, and both 
were negative for CD45Ra, expressed only on naive T lym- 
phocytes (data  not shown). The analysis of surface expres- 
sion of adhesion receptors revealed that while both clones 
failed to express L-selectin  (LECAM-1/Mel-14),  they expressed 
comparable amounts of CD8, LFA-1, ICAM-1, CD2,  and 
vitronectin receptor (VNR)  (Fig.  5). 
Most revealing was the FACS  |  analysis with mAbs directed 
against CD44  and VLA-4.  Comparing four different anti 
P. yoelii CTL clones, we observed a clear correlation between 
their protective capacity and their levels of expression of CD44 
and, to a lesser degree, of VLA-4. As shown in Fig. 6, pro- 
tective clones YA26 and YA23 displayed levels of CD44 ex- 
pression several  times higher than those of nonprotective YA15 
cells, while the partially protective clone YB8 displayed in- 
termediate levels of CD44. This pattern was observed with 
three different anti-CD44 mAbs (KM  703,  KM 201, and 
IM7.8.1). 
Selection of Cells of the YB8 Clone That Express Low Levels 
of  CD44 Generates  a Nonprotective Subpopulation.  The FACS  | 
analysis of CD44 on the surface of YB8 ceils showed a broad 
distribution of fluorescence (Fig.  6), raising the possibility 
Figure 4.  Cells of the adoptively transferred  protective CTL clone (YA26) "associate"  with parasitized hepatocytes.  Autoradiography of the liver 
section of a mouse infected with sporozoites and injected, 24 h later, with radiolabeled CTL. The mouse was killed 8 h after the adoptive cell transfer. 
Liver sections were processed for histology and autoradiography following standard procedures. (P) Parasitized hepatocyte; (L) labeled YA26 cell (x 2,000). 
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Figure 5.  Expression  of various 
T cell surface molecules in protec- 
tive  (YA26) and  nonprotective 
(YA15) cells. CTL  clones were 
stained with mAbs to various  T cell 
surface molecules, followed  by fluo- 
rescein-conjugated  goat anti-rat or 
goat anti-hamster antibody, and 
analyzed by FACS  |  The relative 
mean fluorescence obtained with 
each mAb is indicated on the top 
right comer of each histogram. The 
region between bars (lower left 
comer of each histogram) represents 
the background fluorescence ob- 
tained when the cells  were  incubated 
only with fluorescein conjugated 
second antibody. 
that two subpopulations with different protective activities 
could be selected by sorting the cells having high and low 
levels of CD44. Indeed, after two rounds of sorting, we ob- 
tained two subpopulations that we designated YB8-1ow and 
YB8-high.  The YB8-1ow subpopulation expressed levels of 
CD44 similar to those of the nonprotective YA15 clone. The 
YB8-high subpopulation expressed levels of CD44 close to 
those found in the original, nonsorted YB8 cells (Fig.  7 A). 
Both populations expressed comparable amounts of the other 
markers, and displayed similar levels of in vitro cytolytic ac- 
tivity. Interestingly, both subpopulations expressed identical 
levels  of VLA-4 (data not  shown). 
When the cells were adoptively transferred  to naive BALB/c 
mice, the YBS-high subpopulation inhibited the development 
of liver stages by 61%.  In contrast,  the YBS-low ceils had 
no detectable inhibitory effect on the intrahepatocytic para- 
sites  (Fig.  7 B). 
Attempts  to isolate subpopulations expressing high  and 
low levels of VLA-4, after the same procedure as for CD44, 
have so far been unsuccessful. 
Triggering of CD44 Fails to Promote LFA.l-mediated  Adhe- 
sion of Nonprotective YA15 Cells.  R~cent studies have demon- 
strated that  the binding  of anti-CD44  antibodies to the T 
cell surface promotes homotypic T  cell adhesion mediated 
by LFA-1 (11). We therefore decided to determine if YA15 
and YA26 clones differed in their adhesion properties, upon 
triggering  of CD44. 
Incubation of protective YA26 cells with anti-CD44 anti- 
bodies induced a strong homotypic aggregation (Fig. 8 A). 
This aggregation was completely inhibited by the anti-LFA-1 
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Figure 6.  Protective activity of CTL clones corre- 
lates with their expression of CD44 and VLA-4. Four 
different  antimalaria  CTL clones were stained with 
mAbs  against  CD44  or  VLA-4,  and  analyzed  by 
FACS  #. The relative mean fluorescence obtained  for 
each clone is indicated on the top fight corner of each 
histogram.  In previous work (2), it was determined 
that CTL clones YA23 and YA26 eliminate parasit- 
ized cells by 90% or more, while clone YB8 eliminates 
50-60% of the parasitized cells, and YA15 cells have 
no detectable effect. 
antibody (Fig. 8 C). In contrast, anti-CD44 antibodies failed 
to induce aggregation of nonprotective YA15 cells (Fig.  8 
B). In the presence of PMA, however, YA26, as well as YA15, 
cells aggregate strongly (Fig. 8, E and F, respectively). Incu- 
bation of these cells with mAbs to LFA-1 or class I MHC 
(H-2K  d) does not induce aggregation (data not shown), in 
agreement with previous studies with human T  cells (11). 
Discussion 
The basic question we have addressed in this manuscript 
is: What are the factors that confer to certain routine CD8 § 
T  cell clones the capacity to protect against malaria, while 
other CD8 + clones fail to be protective? 
We found that protective and nonprotective CTL clones 
do not differ in their fine epitope specificity and display,  in 
vitro, similar levels of lysis and DNA degradation of target 
cells. Their pattern of production of lymphokines and granule- 
associated proteins does not correlate with their in vivo an- 
tiplasmodial activity. 
The two clones, however, differed strikingly with regard 
to two other characteristics. First,  upon adoptive transfer, 
we observed that T cells from the protective clone were as- 
sociated with 30-40% of infected hepatocytes, while the as- 
sociation of the nonprotective T cell clone with infected he- 
patocytes was a rare event. 
Second, we detected a pronounced difference in the ex- 
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Figure 7.  Selection of YB8 subpopulations  expressing high and low 
levels of CD44, generates protective and nonprotective  subpopulations. 
(A)  FACS  |  analysis of the  two  subpopulations,  YB8/low  ( ..... )  and 
YBS/high (  ), obtained by sorting the YB8 CTL clone, using a mAb 
to CD44. (B) The capacity of these two subpopulations to inhibit parasite 
development upon adoptive transfer to sporozoite infected mice. 2.5  x 
107 T cells of each subclone were adoptively transferred to naive BALB/c 
mice 6 h before the challenge with viable P. yoelii sporozoites. The percent 
inhibition  of liver stage development  was calculated  in relation to the amount 
of parasite rKNA present in the liver of control mice, challenged with 
sporozoites, but not injected with T cells. Results are expressed as the 
mean value of four mice  +  SE. 
pression of CD44 and VLA-4 in protective vs. nonprotective 
clones. By FACS  |  analysis, we found that the amount of CD44 
and VLA-4 expressed  in two protective clones (YA26 and 
YA23) was several times greater than that of the nonprotec- 
tive clone YA15. 
Another clone, YB8, which upon adoptive transfer induced 
intermediate levels of protection, i.e., a 50-60% reduction 
of the hepatic parasite load, displayed intermediate levels of 
CD44 and VLA-4.  More important, we selected two sub- 
populations of clone YB8 expressing low and high levels of 
CD44. Upon adoptive transfer into infected mice, the sub- 
population CD44 low failed to induce any protection, while 
the CD44 high subpopulation reproduced the level of inhi- 
bition seen with the original YB8 done. It is noteworthy 
that both subpopulations expressed identical levels of VLA-4, 
supporting the notion that the protective activity of antimalaria 
CTL clones correlates primarily with the expression of CD44. 
Lymphoid  cells express a CD44 molecule with an apparent 
molecular mass of 85 kD, which has been implicated in sev- 
eral functions related to cell adhesion and migration (12). This 
molecule participates in the binding of lymphoid cells to high 
endothelial venules (13), to hyaluronate (14-16),  and to ex- 
tracellular matrix proteins (17). Also highly relevant to our 
observations is the fact that CD44 has been shown to mediate 
not only adhesion of activated T lymphocytes to human um- 
bilical vein endothelial cells, but also their transendothelial 
migration (18). 
The observed differences in CD44 expression by individual 
antimalaria  CD8 + CTL clones, detected by FACS  |  analysis, 
might reflect different amounts of CD44 and/or the preferen- 
tial expression, by certain CTL clones, of a different isoform 
of this protein that is recognized less effaciently by the mAbs 
we used. The occurrence of distinct isoforms of CD44, which 
differ by the insertion of some amino acids into the extracel- 
lular domain of this protein, has recently been documented 
for human foreskin fibroblasts (19), the human myelomono- 
cytic cell line KGla (20),  and the rat pancreatic  carcinoma 
Bsp73/ASML (21). It has also been found that the presence 
of some of these isoforms confers metastatic properties to 
carcinoma and lymphoma cells (21, 22). In view of these data 
on human and rat CD44 isoforms, it will be important to 
determine whether the different expression of CD44 we ob- 
served between protective and nonprotective CD8 §  CTL 
clones is only a quantitative and/or also a qualitative trait. 
The elucidation of this matter will require the structural char- 
acterization of these proteins and, if feasible, also the trans- 
fection of the CD44 gene from protective into nonprotective 
CTL clones. 
The CD44 molecule has also been implicated in signal trans- 
duction, since triggering of CD44 by specific mAbs promotes 
LFA-l-mediated homotypic adhesion of T cells (11), and also 
heterotypic adhesion of B cells to follicular dendritic cells (23). 
It is therefore plausible  that the levels of CD44 expression 
may determine the capacity of the antimalaria CD8 + T cells 
to adhere to endothelial cells and migrate through intercel- 
lular spaces in the liver. In this process, the triggering of CD44 
may have a crucial role in modulating LFA-l-mediated adhe- 
siveness of the T cell clones to distinct cell types that express 
LFA-1 ligands (e.g., ICAM-1). This interpretation is supported 
by our finding that cells of the protective clone YA26 dis- 
played strong LFA-l-mediated aggregation upon triggering 
of CD44,  while YA15 cells were completely refractory to 
aggregation. Detailed in vivo morphological studies, using 
EM, and in vitro assays, will be required to determine whether 
the expression of CD44 correlates with the capacity of these 
CTL clones to adhere  and/or migrate through endothelial 
and other liver cells. 
Another adhesion molecule, VLA-4,  was also expressed 
more abundantly on protective than nonprotective clones. 
As a member of the integrin family of adhesion molecules, 
VLA-4, like CD44, has been implicated in the homotypic 
and heterotypic adhesion of lymphocytes. This molecule is 
known to bind to V-CAM-1 (24), which is expressed on ac- 
tivated endothelial cells, and to a peptide (CS-1) of human 
plasma fibronectin (25). At present, we cannot discard the 
possibility that the higher expression of VLA-4 in the pro- 
902  Adhesion Molecules and In Vivo Cytotoxicity of Cloned CD8 + Cells Figure 8.  Triggering  of CD44 induces LFA-l-mediated  homotypic  aggregation of protective YA26 cells. A protective (YA26) and a nonprotective 
(YA15) CTL clone were incubated with mAb to CD44 alone (A and B) or with mAb to CD44 and to LFA-1 (C and D). In E and F, each of these 
CTL clones was incubated with PMA. After 2 h of incubation, the cultures were photographed (x200). 
tective YA23 and  YA26 clones contributes,  together  with 
CD44,  to  the  ability  of these clones  to  eliminate  malaria 
parasites. 
In  conclusion,  our  studies  have  shown  that  antimalaria 
CD8 + CTL clones differ in the expression of certain  adhe- 
sion molecules. We found that these differences correlate closely 
with the ability to associate with parasitized liver cells and, 
most importantly, with the capacity of these CTL clones to 
inhibit the development and protect against intrahepatocytic 
stages of malaria parasites.  Because nonprotective CTL clones 
are fully cytolytic in vitro,  they might  not be defective re- 
garding their adhesion to target cells.  It is likely that  these 
cells migrate inefftciently through the liver parenchyma and 
therefore rarely come into the vicinity of infected hepatocytes. 
Previous  studies  have  shown  that  resting  and  antigen- 
activated T cells differ significantly in their expression of cer- 
tain adhesion molecules, including CD44. The present study 
shows  that  these  differences  can  also  be  detected  among 
antigen-activated  CD8 §  T  cells.  The  characterization  and 
the perspective of modulating the regulatory mechanisms that 
control the expression of these adhesion molecules may, in 
the future, increase greatly the ef~cacy of certain immuno- 
logical  interventions,  such  as  the  therapeutic  transfer  of 
lymphokine-activated  killer  cells and vaccines. 
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